EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France

BACKGROUND EQOFIX is a medicoeconomic study that analyzed the health‐related quality of life (HRQoL) and costs of care of the moderate and severe forms of hemophilia B, treated on demand or by prophylaxis with either plasma‐derived Factor IX (pdFIX) or recombinant FIX (rFIX). STUDY DESIGN AND METHOD...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Transfusion Ročník 55; číslo 7; s. 1787 - 1797
Hlavní autori:	Polack, Benoît, Calvez, Thierry, Chambost, Hervé, Rothschild, Chantal, Goudemand, Jenny, Claeyssens, Ségolène, Borel-Derlon, Annie, Bardoulat, Isabelle, Maurel, Frédérique, Woronoff-Lemsi, Marie-Christine
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Blackwell Publishing Ltd 01.07.2015 Wiley Wiley Subscription Services, Inc
Predmet:	[INFO.INFO-BT]Computer Science [cs]/Biotechnology Adolescent Adult Child Cohort Studies Costs Costs and Cost Analysis Economics and Finance Factor IX Factor IX - administration & dosage Factor IX - economics Female France Hematology Hemophilia Hemophilia B Hemophilia B - drug therapy Hemophilia B - economics Hemorrhage Hemorrhage - economics Hemorrhage - prevention & control Human health and pathology Humanities and Social Sciences Humans Life Sciences Male Middle Aged Quality of Life Santé publique et épidémiologie France
ISSN:	0041-1132, 1537-2995, 1537-2995
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!